Psychedelic Retreats: Mushrooms, Ayahuasca & San Pedro

One retreat label, very different worlds

“Psychedelic retreat” can bring to mind a candlelit ceremony, a quiet room with music, or a rural stay built around conversation and reflection. The phrase covers a wide range of experiences. A mushroom-based programme, an ayahuasca ceremony and an Andean cactus tradition should not be treated as versions of the same thing.

The differences begin with the fungi and plants themselves, but extend to history, language, ritual and the people guiding an event. Their histories connect fungi and plants with communities, landscapes and ways of making sense of unusual experiences. Start with three names you will encounter, then explore the European retreat profiles for more context.

Magic mushrooms, ayahuasca and San Pedro explained

Psilocybin: magic mushrooms and truffles

Psilocybin is found in certain fungi and is converted in the body to psilocin. Its history stretches well beyond today’s retreat industry: the US National Center for Complementary and Integrative Health describes longstanding sacred use among Indigenous peoples in parts of Mexico and Central America.

Accounts of the experience often describe vivid imagery, shifts in emotion and an altered sense of time. These descriptions are possibilities, not a script: a person’s response can be very different from someone else’s. Contemporary programmes may borrow ceremonial language, take a psychological approach, or combine music and quiet reflection. Those frameworks deserve as much attention as the word “mushroom”.

You may also encounter “magic truffles”. These are sclerotia, a different fungal structure containing the same principal psychoactive compounds. The name does not establish that a programme is mild, lawful or appropriate for an individual.

Programme focus: Look at whether the programme centres on inward reflection, ceremonial tradition or a broader wellbeing stay, and what its preparation and follow-up actually involve.

Ayahuasca: Amazonian traditions and ceremony

Ayahuasca is associated with Indigenous Amazonian traditions and refers to a plant preparation, as well as to the vine central to those traditions. Its cultural world includes knowledge passed between generations, music, ritual and community. Peru’s official heritage register records recognition of traditional Amazonian ayahuasca knowledge in 2008. A contemporary European event may draw on some of those elements, but it should explain its relationship to them rather than simply using the word “shamanic”.

Ayahuasca preparations commonly combine DMT with compounds that inhibit monoamine oxidase. That gives medication interactions particular importance and helps explain why ayahuasca is not interchangeable with a psilocybin experience. The US Department of Veterans Affairs evidence review sets out these pharmacological differences.

Programme focus: The ceremonial setting and the tradition being represented. Music, language, leadership and group structure can vary considerably. Ask who is leading, what their training involves and how the cultural knowledge they reference is respected.

San Pedro: the Andean cactus also called huachuma

San Pedro is a tall, columnar cactus associated with Andean and northern Peruvian traditions. It contains mescaline, a different psychedelic compound from psilocybin or DMT. Peyote also contains mescaline, but it is a different cactus with its own cultural history.

There is a living tradition behind the familiar name. In 2022, Peru’s Ministry of Culture recognised traditional San Pedro knowledge and uses as national cultural heritage. That recognition concerns cultural practice; it is not evidence that every modern retreat reproduces the tradition or provides a medical treatment.

San Pedro is sometimes promoted as a “gentle” or “heart-opening” alternative. These are subjective descriptions, not reliable predictions. In controlled research, mescaline has shown a longer duration than psilocybin, and the quality of an experience cannot be reduced to a plant’s reputation.

Programme focus: Its Andean context and the time and attention given to the wider process. Look for a clear account of the tradition, support and reflection, rather than a promise that a particular feeling will occur.

Compare the three at a glance

Other names you may encounter: LSD, ketamine and Bufo do not all belong in the same category. The NIH overview distinguishes classic psychedelics from dissociatives such as ketamine. Our Bufo ceremony explainer covers another distinct term. A result or description relating to one substance should not be transferred to another.

Portugal, Spain and the UK: understand the legal context

Portugal: Decriminalisation does not mean legalisation. Law 30/2000 addresses personal-use activities through an administrative framework; it does not provide blanket permission for supply or commercial retreats.

Spain: Private settings and association membership should not be mistaken for general legal authorisation. Spain’s Criminal Code, article 368 addresses trafficking and facilitating illegal consumption. The substance, preparation and activity all matter.

UK: The Home Office controlled drugs list includes several commonly discussed psychedelics as Class A substances. A retreat, ceremony or sacrament label does not itself create an exemption. Check current official guidance for the relevant country and substance.

How a retreat differs from psychedelic-assisted therapy

A commercial retreat and an authorised clinical study have different purposes and safeguards. Research follows a defined protocol, with eligibility criteria, ethics review and specific outcomes to measure. Psychological support and a controlled research environment are part of the intervention being studied.

“Research-based” on a retreat website does not establish a connection to a trial or a licensed clinical service. If an event is presented as research, look for the study title, sponsor and public registry entry. The MHRA explains the UK trial approval process.

What the research adds to the picture

Research into potential therapeutic uses is an important part of this subject. It is also specific: a study of psilocybin in selected participants cannot establish the effects of ayahuasca, San Pedro or a commercial retreat. The European Union Drugs Agency’s overview explains the difference between emerging therapeutic research and use outside regulated settings.

Read a promising finding alongside its comparison group, follow-up period and limitations. Personal accounts can illuminate an experience, but they cannot show how often an outcome occurs or predict what another person will experience.

What gives a programme its character?

The substance is only one part of the description. A residential stay may place equal emphasis on music, discussion, meditation, time outdoors or individual reflection. Look at how those elements fit together and whether the organiser explains its cultural and professional framework in plain language.

Useful detail includes group size, language, the balance between group and individual support, and what “integration” means in practice. These specifics tell you more than promises of a breakthrough. A moving testimonial and a claim to treat a health condition require different kinds of evidence.

The people, boundaries and support matter

Find out who is responsible for assessment, who is present during the programme and who responds to an emergency. A facilitator’s training, a traditional lineage and a regulated clinical qualification mean different things. If someone claims a healthcare profession, verify the relevant registration rather than relying on a title in a biography.

Consent should be concrete: how are touch, personal sharing, recordings and confidentiality handled? Can someone decline an activity or raise a concern privately? Clear boundaries and a complaints route matter especially in settings where suggestibility and vulnerability may be increased.

Keep health questions individual

Psychedelics can produce fear, confusion and panic as well as experiences described positively. Physical effects can include nausea, increased heart rate and raised blood pressure. Medication interactions and psychiatric vulnerabilities also matter, as the NIH overview explains.

Discuss your circumstances with an appropriately qualified clinician. Do not stop or alter prescribed medicines on a retreat organiser’s advice. An online form cannot establish safety for everyone, and a retreat should not delay care for an existing health condition.

Integration: what happens after the experience?

Integration usually means reflecting on an experience and considering its place in ordinary life. It may involve conversation, writing or ongoing professional support, but the term does not describe one standard service. Ask who provides the support, how long it lasts and whether additional sessions cost extra.

Our guide to integration after a psychedelic retreat explores this further. If your interest is primarily meditation, nature or a quieter routine, those are worth exploring in their own right through spiritual retreats or silent retreats.

Common questions about psychedelic retreats

Sources and further reading

• NCCIH: psilocybin, its history and current research
• RIVM: sclerotia information report, 2014 (PDF; biological background)
• US Department of Veterans Affairs: psychedelic pharmacology comparison
• Peru Ministry of Culture: recognition of traditional San Pedro knowledge, 2022
• NIH: psychedelic and dissociative drugs
• EUDA: therapeutic research and other psychedelic-use contexts
• Portugal: Law 30/2000
• Spain: Criminal Code, article 368
• UK Home Office: controlled drugs list
• MHRA: UK clinical trial approval

Botanical photographs are credited with their licences beside each image. Provider photographs show the people, spaces or activities described and have image-source links in their captions.

Programmes and legal arrangements can change. Send a correction or an update.